Produktinformation
- Asimadoline [INN]
- Benzeneacetamide, N-((1S)-2-((3S)-3-hydroxy-1-pyrrolidinyl)-1-phenylethyl)-N-methyl-alpha-phenyl-
- Benzeneacetamide, N-(2-(3-hydroxy-1-pyrrolidinyl)-1-phenylethyl)-N-methyl-alpha-phenyl-, (S-(R*,R*))-
- Benzeneacetamide, N-[(1S)-2-[(3S)-3-hydroxy-1-pyrrolidinyl]-1-phenylethyl]-N-methyl-α-phenyl-
- Benzeneacetamide, N-[2-(3-hydroxy-1-pyrrolidinyl)-1-phenylethyl]-N-methyl-α-phenyl-, [S-(R*,R*)]-
- Emd 61753
- N-((alpha S)-alpha-((3S)-3-Hydroxy-1-pyrrolidinyl)methyl)benzyl)-N-methyl-2,2-diphenylacetamide
- N-((alphaS)-alpha-(((3S)-3-Hydroxy-1-pyrrolidinyl)methyl)benzyl)-N-methyl-2,2-diphenylacetamide
- N-[(1S)-2-[(3S)-3-Hydroxy-1-pyrrolidinyl]-1-phenylethyl]-N-methyl-α-phenylbenzeneacetamide
- N-{(1S)-2-[(3S)-3-hydroxypyrrolidin-1-yl]-1-phenylethyl}-N-methyl-2,2-diphenylacetamide
- Mehr Synonyme anzeigen
- Unii-D0Vk52Nv5M
Asimadoline is a compound that has been shown to have analgesic and anti-inflammatory effects. It binds to κ-opioid receptors, which are found in the central nervous system and gastrointestinal tract. Asimadoline also binds to kappa-opioid receptors, which are located on immune cells in the brain and spinal cord. This drug has been shown to inhibit the production of pro-inflammatory cytokines, such as TNF-α and IL-1β, which may be due to activation of κ-opioid receptors. Asimadoline has also been shown to inhibit Pgp substrate activity, which may explain its ability to treat bowel disease, primary sclerosing cholangitis (PSC), inflammatory bowel disease (IBD), diabetic neuropathy, and antinociceptive disorders.
Chemische Eigenschaften
Technische Anfrage zu: 3D-DGA20546 Asimadoline
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.